In a first-in-human Phase 1 trial, researchers from the University of Minnesota used CRISPR/Cas9 gene-editing technology to modify tumor-infiltrating lymphocytes…
Browsing: Clinical Updates
A new Nature Communications Medicine article dives into the expanding role of ctDNA-based liquid biopsies in colorectal cancer. From guiding…
Obesity is rising in IBD populations, and GLP-1 receptor agonists may offer more than just weight control. In a series…
As newer noninvasive screening tools flood the market, the fecal immunochemical test (FIT) continues to hold its ground—quietly, effectively, and…
A quiet revolution in GI care may be underway. At DDW 2025, researchers presented findings suggesting that advanced practice providers…
Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic…
The American Society for Gastrointestinal Endoscopy (ASGE) has released updated 2025 clinical guidelines for gastroesophageal reflux disease (GERD)—a condition impacting…
On May 7, 2025, Priority Health announced a strategic partnership with Ayble Health to launch a comprehensive digestive health program…
Colorectal cancer screening saves lives—but how do common methods like colonoscopy and non-invasive screening methods compare in their environmental effects?…
The use of GLP-1 receptor agonists (GLP-1 RAs) has more than doubled since 2022, contributing to a decline in bariatric…